Try it
Pharmacology · Chemotherapy: carboplatin versus cisplatin
Sample itemA patient with ovarian cancer has poor renal function and prior hearing loss, and a platinum agent with less nephrotoxicity, ototoxicity and emesis is needed. Which is chosen, and what is its main dose-limiting effect?
Original practice item, not a recalled exam question. Nothing here is recorded.
The answer and the reasoning
B. Carboplatin, with myelosuppression, especially thrombocytopenia
Carboplatin is less nephrotoxic, ototoxic and emetogenic than cisplatin, with myelosuppression being dose-limiting. Oxaliplatin causes a cold-triggered peripheral neuropathy.
Option by option
A. Carboplatin, with cold-induced neuropathy
Cold-induced neuropathy is characteristic of oxaliplatin.
B. Carboplatin, with myelosuppression, especially thrombocytopenia (correct)
Correct. Carboplatin trades renal toxicity for marrow suppression.
C. Cisplatin, with myelosuppression
Cisplatin is more nephrotoxic and ototoxic.
D. Oxaliplatin, with nephrotoxicity
Oxaliplatin is neurotoxic rather than nephrotoxic.
Source note: Original NextPrep sample item — pending expert review. This item is original practice material awaiting independent expert review, so confirm important facts in a standard textbook.
More Pharmacology questions
- Emergency drugsA patient develops stridor, wheeze and hypotension minutes after an injection. What is t…
- AntiepilepticsWhat is the preferred first-line drug for a patient in generalised convulsive status epi…
- AntimicrobialsWhich drug can cause a disulfiram-like reaction when taken with alcohol?
- AntiepilepticsWhich drug is preferred for uncomplicated childhood absence seizures?